Overview

Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye

Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
This is a parallel randomized controlled trial for the treatment of dry eye disease. The main objective is to investigate the efficacy and safety of the use of insulin eye drops in the control of moderate-severe dry eye disease. Topical insulin drops will be compared to the current gold standard treatment, cyclosporin and placebo (artificial tears).
Phase:
Phase 4
Details
Lead Sponsor:
Barbara Burgos Blasco
Treatments:
Cyclosporine
Cyclosporins
Lubricant Eye Drops